Moderna

MRNA · NASDAQ · USD

$190.01+0.57%+$1.07

Close · October 2, 2026

At a glance

Revenue growth
−39.93%
2025 vs 2024
Net margin
-145.2%
2024: -110.0%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total assets10,96111,48812,33812,13512,01012,70414,14215,80315,68016,72918,42619,450
Current assets5,8155,7706,5446,5986,1716,7668,0999,6669,6619,60010,32510,799
Cash and equivalents1,7231,9082,5951,1321,2791,6231,9271,6442,4782,0512,9072,932
Short-term investments3,4153,2973,2043,3723,8524,3525,0985,2236,0106,4725,6974,641
Receivables1031472841,3944573065921,8364233871,0812,146
Inventory280146153332240128117412399295202548
Net property, plant and equipment2,7562,7922,8532,8642,9192,9642,9553,1652,9712,7602,6582,717
Goodwill52.052.052.052.052.052.052.052.052.052.052.052.0
Other intangible assets10911645.047.048.049.040.041.042.043.044.045.0
Long-term investments1,7722,2512,3422,1522,3802,4242,5082,3582,3573,6914,7435,359
Current liabilities2,5342,3951,9871,6811,5721,6042,2062,2012,3632,3803,0154,385
Accounts payable167161317267175226405373279183520494
Long-term debt591590590—————————
Total debt1,2871,2981,3057347417457471,3551,2691,237——
Total liabilities4,2004,0803,6882,8052,6112,6383,2413,8763,9683,9124,5725,995
Total equity (incl. minority)6,7617,4088,6509,3309,39910,06610,90111,92711,71212,81713,85413,455
Retained earnings5,0985,8807,2238,0498,2499,07410,04511,16511,15212,43113,60613,389